Compressed SPEEDER Technology for 3D Exams On 1.5T MR, Enabling High-speed MR Imaging Now FDA Approved

December 21, 2020

Compressed SPEEDER technology for 3D exams has been FDA-cleared for 3D sequences on Canon Medical Systems USA, Inc.’s Vantage Orian 1.5T MR system, so clinicians can easily expect to scan at least twice as fast, and even faster in many clinical scenarios*.

Compressed SPEEDER 3D** boosts MRI scan times during 3D sequences for exams such as surgical planning and orthopedic applications by reconstructing full resolution images from under-sampled data through iterative reconstruction. The innovative technique overcomes many of the limitations inherent to traditional parallel imaging and allows for greater acceleration. The system can even further accelerate exams with Fast3D, a new technique that can be used in combination with Compressed SPEEDER 3D to help make exams even quicker.

Compressed SPEEDER technology is available as an option in an all-new new version of M-Power software for the Vantage Orian 1.5T, which is also available with Fat Fraction Quantification**, an application integrated directly onto the system’s console to help clinicians image and quantify fatty liver disease. The application acquires six MR echoes at once, allowing for quick diagnoses, detailed severity grading, disease monitoring and treatment response, all in alignment with QIBA standards.

“With 30 percent of the U.S. population suffering from Fatty Liver Disease, the ability to diagnose quickly as well as quantify and monitor the disease has become extremely important to clinicians. Our Fat Fraction Quantification is an ideal solution, and it is on our Vantage Orian 1.5T console so that it can be integrated into existing workflow,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc.

Furuyama concluded, “At Canon Medical, our priority is to support our customers and their patients by providing them with timely advancements that can impact their outcomes and workflow. With the help of Compressed SPEEDER for 3D exams along with Fat Fraction Quantification, healthcare providers can offer a quick and comfortable experience for their patients.”


* Actual acceleration factors vary by case. Maximum acceleration factor is up to 16 times.

** Compressed SPEEDER 3D and Fat Fraction Quantification are both optional. Fat Fraction Quantification is FI-Quant.

Vantage Orian and Made for life are trademarks of Canon Medical Systems.

SourceCanon

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.